|
Volumn 357, Issue 9261, 2001, Pages 1027-1032
|
Systemic lupus erythematosus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIMALARIAL AGENT;
BROMOCRIPTINE;
CHLOROQUINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
HORMONE;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN;
METHOTREXATE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PRASTERONE;
THALIDOMIDE;
WARFARIN;
ACNE;
AMENORRHEA;
ANTIPHOSPHOLIPID SYNDROME;
CAUSE OF DEATH;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
HIGH RISK PREGNANCY;
HIRSUTISM;
HORMONAL THERAPY;
HUMAN;
INCIDENCE;
MENSTRUAL IRREGULARITY;
NEPHRITIS;
NEUROPSYCHIATRY;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
PROGNOSIS;
PUBLICATION;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOSIS;
|
EID: 0035978096
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(00)04239-2 Document Type: Conference Paper |
Times cited : (274)
|
References (91)
|